Outcomes of Autologous Hematopoietic Stem Cell Transplant in Sporadic Late Onset Nemaline Myopathy with Associated Monoclonal Gammopathy of Unknown Significance

被引：0
|
作者：
Kansagra, Ankit J. [1 ]
Buadi, Francis [2 ]
Milone, Margherita [3 ]
Naddaf, Elie [3 ]
Gertz, Morie [2 ]
Dispenzieri, Angela [2 ]
Kumar, Shaji [2 ]
Dingli, David [2 ]
Lacy, Martha Q. [2 ]
Kapoor, Prashant [2 ]
Gonsalves, Wilson I. [2 ]
Warsame, Rahma [2 ]
Muchtar, Eli [2 ]
Kyle, Robert [2 ]
Kourelis, Taxiarchis [2 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Hematol & Bone Marrow Transplant, Dallas, TX 75390 USA
[2] Mayo Clin, Div Hematol, Rochester, MN USA
[3] Mayo Clin, Dept Neurol, Rochester, MN USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2018年 / 24卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
146
引用
收藏
页码：S122 / S123
页数：2
相关论文
共 50 条
  • [21] Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance (SLONM-MGUS): An alternative treatment using cyclophosphamide-thalidomide-dexamethasone (CTD) regimen
    Kumutpongpanich, Theerawat
    Owattanapanich, Weerapat
    Tanboon, Jantima
    Nishino, Ichizo
    Boonyapisit, Kanokwan
    NEUROMUSCULAR DISORDERS, 2018, 28 (07) : 610 - 613
  • [22] Sporadic Late-onset Nemaline Myopathy Associated with Sjögren's Syndrome
    Hamaguchi, Tsuyoshi
    Nishino, Ichizo
    Hirano, Yasuki
    Uchida, Nobuaki
    Fujita-Nakata, Michiyo
    Nakanishi, Megumi
    Sakai, Tomoyuki
    Asahina, Masato
    INTERNAL MEDICINE, 2024, 63 (19) : 2683 - 2687
  • [23] MONOCLONAL GAMMOPATHY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT AS A POSSIBLE MARKER FOR GVHD ONSET
    Monaco, F.
    Zallio, F.
    Catania, G.
    Corsetti, M. T.
    Mele, L.
    Dallavalle, F.
    Tamiazzo, S.
    Baraldi, A.
    Salvi, F.
    Pini, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S293 - S294
  • [24] Autologous peripheral blood stem cell transplantation for peripheral neuropathy secondary to monoclonal gammopathy of unknown significance
    Lee, YC
    Came, N
    Schwarer, A
    Day, B
    BONE MARROW TRANSPLANTATION, 2002, 30 (01) : 53 - 56
  • [25] Autologous peripheral blood stem cell transplantation for peripheral neuropathy secondary to monoclonal gammopathy of unknown significance
    YC Lee
    N Came
    A Schwarer
    B Day
    Bone Marrow Transplantation, 2002, 30 : 53 - 56
  • [26] Autologous hematopoietic stem cell transplantation for non-AL amyloidosis monoclonal gammopathy of renal significance
    Liu, Mengnan
    Zhao, Liang
    Guo, Jinzhou
    Chen, Wencui
    Wu, Xiaomei
    Xu, Weiwei
    Huang, Xianghua
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2025,
  • [27] Reader response: Sporadic late-onset nemaline myopathy: Clinical spectrum, survival, and treatment outcomes
    Chahin, Nizar
    Karam, Chafic
    NEUROLOGY, 2020, 94 (24) : 1109 - 1110
  • [28] Editors' note: Sporadic late-onset nemaline myopathy: Clinical spectrum, survival, and treatment outcomes
    Galetta, Steven
    Ganesh, Aravind
    NEUROLOGY, 2020, 94 (24) : 1109 - 1109
  • [29] Author response: Sporadic late-onset nemaline myopathy: Clinical spectrum, survival, and treatment outcomes
    Naddaf, Elie
    Milone, Margherita
    Kansagra, Ankit
    Buadi, Francis
    Kourelis, Taxiarchis
    NEUROLOGY, 2020, 94 (24) : 1110 - 1111
  • [30] High-dose melphalan and autologous hematopoietic stem cell transplant in patient with C3 glomerulonephritis associated with monoclonal gammopathy
    Lepori, Nicola
    Cheungpasitporn, Wisit
    Sethi, Sanjeev
    Murray, David
    Kumar, Shaji
    Leung, Nelson
    Giridhar, Karthik V.
    Fervenza, Fernando C.
    CLINICAL NEPHROLOGY, 2018, 89 (04) : 291 - 299
12345